Abstract
The face-to-face interactions of 43 polydrug-with-cocaine-using mothers and their infants at 3 and 6 months were compared to 17 non-cocaine-but other-drug-using mothers and 21 mothers who used no drugs during their pregnancy. Coders blind to mothers' drug use status scored 3 min of face-to-face interactions for 16 measures of maternal and infant interactive behaviors. A principal component of 7 behaviors formed a measure of maternal attentiveness; a principal component of 5 behaviors formed a measure of mother-infant dyadic organization; and a principal component of 4 behaviors formed a measure of infant readiness to interact. A measure of maternal interruption was computed as the mean standard score of 3 additional interruptive behaviors. At 3 and 6 months, polydrug-with-cocaine-using mothers were less attentive to interactions, and polydrug-with-cocaine-using mothers and their infants engaged in fewer dyadic interactions than either non-cocaine or non-drug-using mothers. Compared to 3 months, polydrug-with-cocaine-using mothers at 6 months were less attentive to interactions and more frequently interrupted interactions by looking away, redirecting the infant, or withdrawing, whereas non-cocaine-using and non-drug- using mothers showed no change or an improvement in attentiveness to interactions and a decrease in interruptions. No differences emerged in the interactive behaviors of the infants of polydrug- with-cocaine-using, non-cocaine-using, or non-drug-using mothers. Cocaine use represents a significant risk for diminished parental attentiveness and responsiveness to infants and for diminished interactiveness in infants.
Original language | English |
---|---|
Pages (from-to) | 489-502 |
Number of pages | 14 |
Journal | Infant Behavior and Development |
Volume | 20 |
Issue number | 4 |
DOIs | |
State | Published - 1997 |
Bibliographical note
Funding Information:and The National Institute on Drug Abuse (NIDA). Additionally, the mothers are part of an intervention project supported by NIDA and Dr. Mayes is supported by a research scientist development award (K02) from NIDA.
Funding
and The National Institute on Drug Abuse (NIDA). Additionally, the mothers are part of an intervention project supported by NIDA and Dr. Mayes is supported by a research scientist development award (K02) from NIDA.
Funders | Funder number |
---|---|
National Institute on Drug Abuse | K02 |
Keywords
- Cocaine-using mothers
- Cocaine/crack
- Mother-infant interaction
- Reciprocity